Взаимовлияние атеросклероза и старения: есть ли место для дискуссий?

Литература:
1. Lakatta EG. Age-associated cardiovascular changes in health: impact on cardiovascular disease in older persons. Heart Fail Rev 2002; 7: 29-49
2. Tolmunen T, Lehto SM, Laukkanen J, et al. Somatic concerns, depressive traits, atherosclerosis and the incidence of cardiovascular disease in ageing Finnish men. J Psychosom Res 2015;79:207-13
3. Miedema MD, Lopez FL, Blaha MJ, et al. Implications of the Eighth Joint National Committee Guidelines for the Management of High Blood Pressure for Aging Adults: Atherosclerosis Risk in Communities Study. Hypertension 2015; 66: 474-80
4. Вихерт A.M., Жданов B.C. Роль возрастных и приспособительных изменений сосудистой стенки в атерогенезе в свете учения академика И. В. Давыдовского об атеросклерозе. Архив патологии 1988; 50: 8-16
5. Costopoulos С, Liew TV, Bennett М. Ageing and atherosclerosis: Mechanisms and therapeutic options. Biochem Pharmacol 2008; 75: 1251-61
6. lurciuc S, Cimpean AM, Mitu F, et al. Vascular aging and subclinical atherosclerosis: why such a "never ending" and challenging story in cardiology? Clin Interv Aging 2017; 12: 1339-45
7. Бойцов С. А., Кухарчук В.В., Карпов Ю.А. и др. Субклинический атеросклероз как фактор риска сердечнососудистых осложнений. Кардиоваскулярная терапия и профилактика 2012; 11: 82-6
8. Kitada М, Ogura Y, Коуа D. The protective role of Sirtl in vascular tissue: its relationship to vascular aging and atherosclerosis. Aging (Albany NY) 2016;8:2290-2307
9. Cunha PG, Boutouyrie P, Nilsson PM, Laurent S. Early Vascular Ageing (EVA): Definitions and Clinical Applicability. Current hypertension reviews 2017; 13: 8-15
10. Kotsis V, Antza C, Doundoulakis I, Stabouli S. Markers of Early Vascular Ageing. Curr Pharm Des2017; 23: 3200-4
11. Andreassi MG, Piccaluga E, Gargani L, et al. Subclinical carotid atherosclerosis and early vascular aging from long-term low-dose ionizing radiation exposure: a genetic, telomere, and vascular ultrasound study in cardiac catheterization laboratory staff. JACC Cardiovasc Interv 2015; 8: 616-27
12. Саджая Л.A., Тихонова Л. А., Малинова Л. И. Возрастзависимая динамика толщины комплекса интима-медиа у лиц пожилого и старческого возраста с артериальной гипертензией. Саратовский научно-медицинский журнал 2011; 7: 611-4). 13. Pursnani S, Diener-West М, Sharrett AR. The effect of aging on the association between coronary heart disease risk factors and carotid intima media thickness: an analysis of the Atherosclerosis Risk in Communities (ARIC) cohort. Atherosclerosis 2014;233:441-6
14. Head T, Daunert S, Goldschmidt-Clermont PJ. The Aging Risk and Atherosclerosis: A Fresh Look at Arterial Homeosta-sis. Frontiers in genetics 2017; 8: 216
15. Сергиенко И. В., Аншелес A.A., Кухарчук В. В. Атеросклероз и дислипидемии: современные аспекты патогенеза, диагностики и лечения. М: 000 «ПатиСС», 2017; 140 с.
16. Пристром M. О, Пристром С. Л., Семененков И. И. Старение физиологическое и преждевременное: современный взгляд на проблему. Международные обзоры: клиническая практика и здоровье 2017: 40-64
17. Giacconi R, Cipriano С, Albanese F, et al. The -174G/ С polymorphism of IL-6 is useful to screen old subjects at risk for atherosclerosis or to reach successful ageing. Exp Gerontol 2004;39:621-8
18. Фомкина О.А., Иванов Д. В., Кириллова И. В., Николенко В.Н. Биомеханическое моделирование артерий головного мозга при разных вариантах конструкции внутричерепных артерий вертебробазилярной системы. Саратовский научно-медицинский журнал 2016; 12 (2): 118-27
19. Altabas V, Altabas К, Kirigin L. Endothelial progenitor cells (EPCs) in ageing and age-related diseases: How currently available treatment modalities affect EPC biology, atherosclerosis, and cardiovascular outcomes. Mech Ageing Dev 2016; 159: 49-62
20. Alique M, Luna C, Carracedo J, Ramirez R. LDL biochemical modifications: a link between atherosclerosis and aging. Food & nutrition research 2015; 59: 29240
21. Kubes P. Nitric oxide-induced microvascular permeability alterations: a regulatory role for cGMP Am J Physiol 1993; 265: H1909-15
22. Graier WF, Wascher TC, Lackner L, et al. Exposure to elevated D-glucose concentrations modulates vascular endothelial cell vasodilatory response. Diabetes 1993; 42: 1497-505
23. Lyons TJ, Jenkins AJ. Lipoprotein glycation and its metabolic consequences. CurrOpin Lipidol 1997; 8: 174-80
24. Stahl W, Sies H. Antioxidant defense: vitamins E and С and carotenoids. Diabetes 1997; 46 (Suppl 2): S14-8
25. Szczeklik A, Gryglewski RJ. Low density lipoproteins (LDL) are carriers for lipid peroxides and inhibit prostacyclin (PGI2) biosynthesis in arteries. Artery 1980; 7: 488-95
26. Dorighello GG, Paim BA, Leite AC, et al. Spontaneous experimental atherosclerosis in hypercholesterolemic mice advances with ageing and correlates with mitochondrial reactive oxygen species. Exp Gerontol 2017
27. Higashi Y, Quevedo HC, Tiwari S, et al. Interaction between insulin-like growth factor-1 and atherosclerosis and vascular aging. Frontiers of hormone research 2014; 43: 107-24
28. Schneider DJ, Absher PM, Neimane D, et al. Fibrino-lysis and atherogenesis in the JCR:LA-cp rat in relation to insulin and triglyceride concentrations in blood. Diabetologia 1998; 41: 141-7
29. Wang M, Kim SH, Monticone RE, Lakatta EG. Matrix metalloproteinases promote arterial remodeling in aging, hypertension, and atherosclerosis. Hypertension 2015; 65: 698-703
30. Jackson RL, Morrisett JD, Gotto AM, Jr. Lipoprotein structure and metabolism. Physiol Rev 1976; 56: 259-316
31. Klimov AN. On the participation of lipoprotein-antibody immune complexes in atherogenesis. Angeiologie 1991; 43: 95-102
32. Klein RL, Carter RE, Jenkins AJ, et al. LDL-contain-ing immune complexes in the DCCT/EDIC cohort: associations with lipoprotein subclasses. J Diabetes Complications 2011; 25: 73-82
33. Sobenin IA, Salonen JT, Zhelankin AV, et al. Low density lipoprotein-containing circulating immune complexes: role in atherosclerosis and diagnostic value. Biomed Res Int 2014; 2014:205697
34. Virella G, Munoz JF, Galbraith GM, et al. Activation of human monocyte-derived macrophages by immune complexes containing low-density lipoprotein. Clin Immunol Immunopathol 1995; 75: 179-89
35. Stout RW. Insulin and atheroma — an update. Lancet 1987; 1: 1077-9
36. Standl E. Hyperinsulinemia and atherosclerosis. Clin Invest Med 1995; 18:261-6
37. Despres P, Flamand M, Ceccaldi PE, Deubel V Human isolates of dengue type 1 virus induce apoptosis in mouse neuroblastoma cells. J Virol 1996; 70: 4090-6
38. DeFronzo RA. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidae-mia and atherosclerosis. Neth J Med 1997; 50: 191-7
39. Nordestgaard BG, Abildgaard S, Wittrup HH, et al. Heterozygous lipoprotein lipase deficiency: frequency in the general population, effect on plasma lipid levels, and risk of ischemic heart disease. Circulation 1997; 96: 1737-44
40. Давиденкова Е.Ф., Либерман И. С, Строев Ю.И. и др. Показатели липидного обмена и перекисного окисления липидов крови у мужчин с учетом наследственной предрасположенности к атеросклеротической сосудистой патологии. Кардиология 1991; 31: 41-5
41. Денисова Т.П. Атеросклероз и сахарный диабет. Саратов: Слово, 1998; 128 с.
42. Pickup JC, Mattock MB, Chusney GD, Burt D. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Di-abetologia 1997; 40: 1286-92
43. Sobenin IA, Zhelankin AV, Sinyov VV, et al. Mitochon-drial Aging: Focus on Mitochondrial DNA Damage in Atherosclerosis: A Mini-Review. Gerontology 2015; 61: 343-9
44. McCully KS. Homocysteine Metabolism, Atherosclerosis, and Diseases of Aging. Comprehensive Physiology 2015; 6: 471-505
45. Kurabayashi M, Yazaki Y. Molecular biology of heart disease. Synopsis of the pathophysiological basis of cardiac hypertrophy, familial hypertrophic cardiomyopathy, long QT syndrome and Marfan syndrome. Intern Med 1996; 35: 243-8.